Conference Coverage

Takotsubo cardiomyopathy incidence, mortality on the rise


 

REPORTING FROM CRT 2018


“We found a number of modifiable and nonmodifiable factors that are associated with a significantly increased mortality, and we think clinicians should be aware of these factors when managing this condition,” Dr. Voudris reported.

Of these risk factors, AKI was associated with the greatest increased odds ratio (OR) with a more than fourfold increased risk of death (OR, 4.18; P less than .001). The presence of PAD (OR, 1.87; P less than .0001) and arrhythmia (OR, 1.88; P less than .0001) almost doubled the risk of in-hospital mortality.

Although females represented 89% of the TCM cases collected during the study period, males with comorbid diseases were at particularly high risk of death, an observation that is consistent with previous reports, according to Dr. Voudris. Relative to women, men were more likely to present with unstable hemodynamics and to develop cardiogenic shock.


Although Dr. Voudris acknowledged that the rising number of hospitalizations for TCM is likely due largely to increasing recognition of this condition, he suggested that there may be other contributing factors to the growing incidence, such as the aging of the U.S. population. He noted that the rise in cases persisted throughout the study period when awareness of TCM might be expected to have improved.

“This is still an uncommon disease, but it is important to recognize,” agreed Sachin Kumar, MD, an interventional cardiologist at the University of Texas Health Science Center at Houston. Moderator of the session in which these data were presented, Dr. Kumar indicated that it is important to increase awareness of the condition to accelerate the time to diagnosis and treatment.

Dr. Voudris reported no financial relationships relevant to this study.

SOURCE: Voudris, KV. CRT 2018.

Pages

Recommended Reading

Abruptio placenta brings increased cardiovascular risk – and soon
MDedge Cardiology
200 cardiovascular drugs now in development
MDedge Cardiology
Mild cognitive impairment rises in heart patients with comorbidities
MDedge Cardiology
ACC Day 2: Late-Breaking Clinical Trial highlights
MDedge Cardiology
Postmenopausal women: Walk farther and faster to reduce heart failure risk
MDedge Cardiology
VEST: Closer tailoring might boost wearable cardioverter defibrillator’s benefit
MDedge Cardiology
Wearable defibrillator cuts mortality in post-MI patients
MDedge Cardiology
CECCY: Carvedilol didn’t curb cardiotoxicity in breast cancer patients
MDedge Cardiology
MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’
MDedge Cardiology
VIDEO: Dabigatran effective for myocardial injury after noncardiac surgery
MDedge Cardiology